Login    Join free Add to favorites    中文
home > news > Annual Pharmaceutical Biotechnology Congress 2018
Industry Updates | New Products | Supplier News | Upcoming Events | business | web
Annual Pharmaceutical Biotechnology Congress 2018

hits:794     Date:10/10/17

Annual Pharmaceutical Biotechnology Congress

Annual Pharmaceutical Biotechnology Congress
May 16-17, 2018 鈭 Singapore
Theme: Latest Research and Development Trends for optimum solutions in the Field
 
Short Name: Pharma Biotech Congress 2018
 
Conferenceseries LLC proudly announces the commencement of 鈥Annual Pharmaceutical Biotechnology Congress鈥 which is going to be held during May 16-17, 2018 at Singapore.
 
About conference
Pharma Biotech Congress 2018 focuses upon 鈥淟atest Research and Development Trends for optimum solutions in the Field鈥.  This Pharma Biotech Congress 2018 focuses on the trends which the biopharmaceutical market is heading on since its launch till the present date and moving on to the projections in future. It takes into its fold the critical developmental procedures, analyses, regulatory factors and also pharmacovigilance including post marketing surveillance and clinical studies. Innovation and compliance to regulatory guidelines are the most critical aspects towards biosimilars and follow on biologics development and successful launching to the market.
 
Why to attend???
Join your peers around the world focused on learning about Biopharmaceutics, Biologics and Biosimilars related advances, which is your single best opportunity to reach the largest assemblage of participants from the Biopharma community, conduct demonstrations, distribute information, meet with current and potential professionals, make a splash with a new research works, and receive name recognition at this 3-day event. World-renowned speakers, the most recent research, advances, and the newest updates in Biologics and Biosimilars are hallmarks of this conference.
 
Target Audience:
Biopharma, Biotech, Pharma Industry CEO, Directors, R&D Researchers
Business Entrepreneurs, Training Institutes, Software developing companies,
Medical Devices Manufacturing Companies, CRO
Data Management, Clinical Trial Conducting Organizations and Companies
Students, Scientists, Researchers, and Faculty of Pharmaceutical Sciences
Universities, Medical Colleges, Researchers from Pharmaceutical background
 
Market Analysis
The opportunity in biopharmaceuticals is big and growing too rapidly to ignore. Today, biopharmaceuticals generate global revenues of $163 billion, making up about 20%of the pharma market. It鈥檚 by far the fastest-growing part of the industry: biopharma鈥檚 current annual growth rate of more than 8% is double that of conventional pharma, and growth is expected to continue at that rate for the foreseeable future.
 
The world of Big Pharma is not only growing, it's standing on its head. Worldwide spending for prescription branded drugs and generic medicines will jump 30% from 2013-2018 at compound annual growth rate of over 5% leading to a jaw-dropping $1.3 trillion in annual global drug sales. The market is also radically shifting position, with traditional strongholds, such as Japan and Europe, flipping over, and emerging markets, such as China, becoming the head. The result is that healthcare investors need a new strategy; they need a way to keep an eye on emerging markets so they aren't left in the lurch because they don't understand the true engines for growth in their holdings. Germany is the leading pharmaceutical market in Europe, but its growth has also slowed to a crawl. The German drug sector is expected to expand at a modest 1.7% rate from 2015 to 2020. Life science is considered one of the most promising sectors of the Austrian economy. Austrian biotech firms are predominantly companies with a pure research focus, over half of which are involved in the health sector. A high percentage of companies work in research and the research rate of the Austrian biotechnology industry stand at 21%. Small and medium enterprise accounts for the majority of Austrian pharmaceutical firms, with large-scale companies at just 10%.
 
  • Session/Tracks
  • Biopharmaceuticals
  • Novel Approaches in Biopharmaceutics
  • Nanoparticles in Biopharmaceuticals
  • Biotechnology in Health Care
  • Formulation of Biotech Products
  • Agriculture Biotechnology
  • Advances in Biotech Manufacturing
  • Biotechnology and its Applications
  • Biopharmaceutical Engineering
  • Chemical Biotechnology
  • Biomass and Bioenergy
  • Industrial and Microbial Biotechnology
  • Biopharmaceutical Production in Transgenic Animals
  • Development on Recombinant Protein
  • Biotech Companies and Market Analysis
  • Biotechnological Products
  • Biopharmaceutical Pharmacovigilance
  • Bioavailability/Bioequivalence on Biopharmaceutical Products
  • Clinical Trials on Biopharmaceutical Products
  • Drug Disposition & Pharmacokinetics
  • Pharmacodynamics
  • Nanoparticles-An Innovative Drug Delivery System
 
About City
Singapore, officially the Republic of Singapore, is a sovereign city-state and island country in Southeast Asia. It lies off the southern tip of the Malay Peninsula and is 137 kilometres (85 mi) north of the equator. The country's territory consists of the lozenge-shaped main island, commonly referred to as Singapore Island in English and Pulau Ujong in Malay, and more than 60 significantly smaller islets. Singapore is separated from Peninsular Malaysia by the Straits of Johor to the north and from Indonesia's Riau Islands by the Singapore Strait to the south. The country is highly urbanized, and little of the original vegetation remains. The country's territory has consistently expanded through land reclamation.
 
Singapore's progress over the past three decades has been remarkable, yet the island has not been overwhelmed by development. Visitors will discover a wealth of historical treasures from the past, in the beauty of older buildings, values and traditions that have survived in the face of profound social and geographical change.
 
Singapore is both an island and a country, but perhaps its best description is that of city-state. Like the great city-states of the past, it offers civilization and order in the highest degree. Its combination of Western-style development and Eastern-style calm seems to present the best of both hemispheres: It's a modern metropolis where you feel safe walking the streets, and it's an Asian business center that's a model of efficiency. Singapore is also a multicultural city, and close to one-quarter of its population are expatriates or foreign workers from all over the world. Known for its desire to become the technology hub of Asia, Singapore is the most wired country in the region.
 
Though physically small, Singapore is an economic giant. It has been Southeast Asia's most modern city for over a century. The city blends Malay, Chinese, Arab, Indian and English cultures and religions. Its unique ethnic tapestry affords visitors a wide array of sightseeing and culinary opportunities from which to choose. A full calendar of traditional festivals and holidays celebrated throughout the year adds to its cultural appeal. In addition, Singapore offers luxury hotels, delectable cuisine and great shopping! The island nation of the Republic of Singapore lies one degree north of the Equator in Southern Asia. The country includes the island of Singapore and 58 or so smaller islands. Because of its efficient and determined government, Singapore has become a flourishing country that excels in trade and tourism and is a model to developing nations. The capital city, also called Singapore, covers about a third of the area of the main island.
 
Contact us
 
Drop us an email for Program enquiry.
Sponsors / Exhibiting / Advertising.
pharmabiotek@annualcongress.net
General Queries
Related News>> more
advertisement

Copyright(C) 2006-2017 Bio-Equip    E-mail:web@bio-equip.cn   娌狪CP澶06040519鍙